Influenza A and influenza B are the two types of flu virus responsible for seasonal outbreaks every winter. They cause similar symptoms, lead to comparable rates of hospitalization and death in adults, and respond to the same antiviral medications. The real differences lie under the surface: how the viruses are classified, how quickly they mutate, who they tend to hit hardest, and why only one of them can trigger a pandemic.
How They’re Classified
Influenza A viruses are sorted into subtypes based on two proteins on their surface: hemagglutinin (H) and neuraminidase (N). That’s where names like H1N1 and H3N2 come from. More than 130 subtype combinations have been identified in nature, mostly in wild birds, and many more are theoretically possible because these viruses readily swap genetic material with one another.
Influenza B doesn’t have subtypes. Instead, it’s divided into two lineages: Victoria and Yamagata. For decades, both lineages circulated and flu vaccines included protection against each one. That’s changing. The Yamagata lineage has been virtually undetectable in global surveillance since the COVID-19 pandemic, and a 2024 review in The Lancet Microbe concluded it is likely extinct or on the verge of extinction. As a result, the World Health Organization has recommended switching from four-strain (quadrivalent) vaccines back to three-strain (trivalent) formulations that drop the Yamagata component.
Animal Hosts and Pandemic Risk
This is the most consequential difference between the two types. Influenza A circulates in a wide range of animal species: wild birds, poultry, pigs, horses, dogs, and others. That broad host range gives it opportunities to pick up entirely new surface proteins when viruses from different species mix inside a single animal. This process, called antigenic shift, can produce a dramatically different virus that the human immune system has never encountered. When that happens, you get a pandemic. Every flu pandemic on record, including the 1918, 1957, 1968, and 2009 outbreaks, was caused by influenza A.
Influenza B, by contrast, circulates almost exclusively in humans. Without that animal reservoir, it can’t undergo the same dramatic genetic reshuffling. It still mutates gradually through small, incremental changes (antigenic drift), which is why flu vaccines need updating each year. But it lacks the mechanism for the sudden, wholesale reinvention that makes influenza A uniquely dangerous on a global scale.
Symptoms and Severity
In a doctor’s office, flu A and flu B look nearly identical. Both cause fever, body aches, cough, sore throat, fatigue, and headache. A large CDC study spanning eight flu seasons and covering nearly 25,000 hospitalizations in adults found no significant difference in the proportion of patients admitted to intensive care, the length of hospital stay, or the proportion of deaths between the two types. If you’re an adult sick enough to be hospitalized, flu B is just as serious as flu A.
Children experience a few notable differences. Kids with influenza B are more likely to develop gastrointestinal symptoms like nausea, vomiting, and diarrhea alongside the usual respiratory illness. Young children also tend to remain contagious for longer than adults. One specific precaution applies to flu B in particular: aspirin should never be given to children or teenagers with the flu, but the warning is especially emphasized with influenza B because of its association with Reye’s syndrome, a rare but serious condition affecting the brain and liver.
Seasonal Patterns
Influenza A typically dominates the early part of flu season, often peaking between December and February in the Northern Hemisphere. Influenza B tends to circulate later, sometimes peaking in the spring. In some years, flu B arrives as a “second wave” after flu A cases have already declined, which can extend the overall flu season by several weeks. This pattern isn’t absolute. Some seasons see flu B emerge earlier or even dominate entirely, but the general trend holds.
Because flu A has more genetic diversity and circulates in animals, it’s responsible for the majority of flu cases in most years. Flu B typically accounts for a smaller share, though it can still cause widespread illness, particularly in schools and among children.
Testing and Detection
Rapid flu tests available in clinics and urgent care centers can distinguish between influenza A and B within about 15 minutes. These tests are highly specific, meaning a positive result is very reliable, with at least 95% specificity for both types. Sensitivity is lower, though. FDA-cleared rapid tests must detect at least 80% of true influenza A and B infections compared to the gold-standard PCR test. That means roughly 1 in 5 infections can be missed, particularly early in the illness when viral levels are still low. If your rapid test is negative but your doctor strongly suspects the flu, a more sensitive PCR test can confirm or rule it out.
Treatment Differences
The same antiviral medications work against both flu A and flu B. The most commonly prescribed option works by blocking an enzyme the virus needs to spread from cell to cell, and it’s effective against both types when started within the first 48 hours of symptoms. A newer antiviral that works through a different mechanism has shown a specific advantage against flu B. In a randomized clinical trial, this newer drug reduced the time to symptom improvement by more than 24 hours compared to the older standard treatment in adolescents and adults with influenza B infections.
Starting antiviral treatment early matters most for young children, older adults, pregnant women, and anyone with a weakened immune system or chronic conditions like asthma. For otherwise healthy adults, antivirals can shorten illness by about a day and reduce the risk of complications, but the benefit is greatest when treatment begins as soon as possible after symptoms start.
Why the Distinction Matters for Vaccines
Flu vaccines are reformulated every year based on which strains are expected to circulate. Because influenza A has so many subtypes and mutates through both drift and shift, predicting which A strains to include is one of the biggest challenges in vaccine design. Currently, seasonal vaccines target two influenza A subtypes (H1N1 and H3N2) along with one influenza B lineage (Victoria), now that Yamagata appears to have disappeared from circulation.
The flu vaccine protects against both A and B, so knowing which type you had in a given year doesn’t change whether you should get vaccinated the following season. Both types circulate independently, and immunity from one doesn’t protect you against the other.